GlassScriptPhysician profile
Norton A Elson
NPI 1912941063
$2,212.83
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,353 · 2020: $114 · 2021: $488 · 2022: $259.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $417.81 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $354.69 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $303.19 | 2019 | |
| United Therapeutics Corporation | $297.83 | 2019-2022 | |
| Genzyme Corporation | $219.77 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $183.56 | 2019 | |
| Genentech USA, INC. | $150.00 | 2021 | |
| Grifols USA, LLC | $106.08 | 2019-2022 | |
| Allergan, INC. | $63.00 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $60.24 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.09 | 2019 | |
| Glaxosmithkline, LLC. | $20.43 | 2019 | |
| Mylan Specialty L.P. | $12.14 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norton Elson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.